Oral Oncology
Volume 38, Issue 6 , Pages 557-561 , September 2002

Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance

Received 25 September 2001 ,Accepted 17 October 2001.

References 

  1. Dong J-T, Lamb PW, Rinker-Schaeffer CW, et al.  KAI1 a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995;268(12):884–886
  2. Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 1996;56(15):1751–1755
  3. Ueda T, Ichikawa T, Tamaru J, et al.  Expression of the KAI1 protein in benign prostate cancer. Am J Pathol. 1996;149(5):1435–1440
  4. Haung CL, Kohno N, Ogawa E, Adachi M, Taki T, Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol. 1998;153(3):973–983
  5. Anneroth G, Batsakis JG, Luna M. Malignancy grading of squamous cell carcinoma in the floor of the mouth related to clinical evaluation. Scand J Dent Res. 1987;95:229–249
  6. Pindborg JJ, Reichart PA, Smith CJ, Van der Waal l. Histological typing of cancer and precancer of the oral mucosa. International histological classification of tumors. 2nd. ed.. WHO Berlin: Springer; 1997;
  7. Higashiyama M, Kodama K, Yokouchi M, et al.  KAI1/CD82 expression in non-small cell lung carcinoma is a novel, favorable prognostic factor. Cancer. 1998;83(3):466–474
  8. Hemler ME, Mannion BA, Berdichevski F. Association of TM4SF proteins with integrins: relevance to cancer. Biochem Biophys Acta. 1996;1287(2–3):67–71
  9. Rubinstein E, Naour FL, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR, and VLA integrins. Eur J Immunol. 1996;26(1):2657–2665
  10. Takaoka A, Hinoda Y, Sato S, et al.  Reduce invasive and metastatic potential of KAI1-tranfected melanoma cells. Jpn J Cancer Res. 1998;89:397–404
  11. Carrie W, Rinker-Schaeffer AL, Hawkins AL, et al.  Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 1994;54(1):6249–6256
  12. Martini N, Burt ME, Bains MS, McCormock PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II. Non-small cell lung cancer. Ann Thorac Surg. 1992;54(3):460–466
  13. Dong JT, Suzuki H, Pin SS, et al.  Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 1996;56(1):4387–4390
  14. Matsuura N, Puzon-McLanghlin W, Irie A, Morikawa Y, Kakudo K, Takada Y. Induction of experimental bone metastasis in mice by transfection of integrin α4β1 into tumor cells. Am J Pathol. 1996;148(1):55–61
  15. Mannion BA, Berditchevski F, Kaeft SK, Chen LB, Hemler ME. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associate with integrin α4β1 (CD49d/CD29). J Immunol. 1996;157:2039–2047

PII: S1368-8375(01)00120-8

Oral Oncology
Volume 38, Issue 6 , Pages 557-561 , September 2002

Article Tools

* Image Usage & Resolution